trial · primary record
Pegcetacoplan
C3 Glomerulopathy (C3G)
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2031-01-17 |
| Primary endpoint | Occurrence of Clinically Significant Recurrent Disease |
| Registry ID | NCT07898774 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:27.352Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07898774
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.